retatrutide parkinson's disease trial nct drug therapies in the clinical pipeline: 2015–2024 Insights into Parkinson's Disease Trials
Description
Scientists at the 23andMe Research Institute published a study in Nature that has identified genetic variants associated with weight loss and side effects among those who have taken GLP-1 medications
A previous review of 28 randomized control trials showed that GLP-1s lowered the incidence of respiratory diseases
The fallout has become political, too
Even worse, you could introduce microbial contamination, which not only ruins the experiment but also poses a significant safety risk in any lab environment
What some people lose on a GLP-1 course compresses years of that process into a single treatment window
This consistently causes people to draw slightly less than intended because the plunger appears higher from above
